Disclosure Of Analysis Of Other Comprehensive Income By Item [Text Block]

Innate Pharma - Filing #5981200

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of analysis of other comprehensive income by item [text block]	—	—	—	—	—	—	—	—		—	—	—	—	—	—	—	—	—	—	—
Disclosure of analysis of other comprehensive income by item [abstract]
Disclosure of analysis of other comprehensive income by item [line items]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	— EUR	— EUR	— EUR	— EUR	—	— EUR	504,000 EUR	— EUR	504,000 EUR	504,000 EUR	276,000 EUR	— EUR	994,000 EUR	—	— EUR	— EUR	— EUR	718,000 EUR	— EUR	718,000 EUR
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	— EUR	— EUR	— EUR	— EUR	36,000 EUR	— EUR	—	— EUR	36,000 EUR	36,000 EUR	394,000 EUR	— EUR	— EUR	394,000 EUR	— EUR	— EUR	— EUR	—	— EUR	394,000 EUR